- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 15.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 14.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 8.75M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $515.39K |
| Capex | Q1 2026 · Mar 31, 2025 | $377.84K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.1M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.94M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $0 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $0 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $5.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.57M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.88M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.34M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.27M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.24M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.89M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.68M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.17M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.46M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $859.22K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $385.64K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $16.64K |
| Rd Expense | Q1 2026 · Dec 31, 2025 | $7.74K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$918.38K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.62M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$645.17K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $400.66K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $529.86K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.21M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.64M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.61M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $3.17M |